The U.S. Food and Drug Administration (FDA) recently finalized the guidance “Multiple Endpoints in Clinical Trials,” which advises drug sponsors on how to separate analyses of primary endpoints – ...
The US Food and Drug Administration has issued new guidance for industry about designing and interpreting clinical trials that use multiple endpoints, all to avoid making the types of mistakes than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results